Cargando…

Between-tumor and within-tumor heterogeneity in invasive potential

For women with access to healthcare and early detection, breast cancer deaths are caused primarily by metastasis rather than growth of the primary tumor. Metastasis has been difficult to study because it happens deep in the body, occurs over years, and involves a small fraction of cells from the pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmanaban, Veena, Tsehay, Yohannes, Cheung, Kevin J., Ewald, Andrew J., Bader, Joel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994152/
https://www.ncbi.nlm.nih.gov/pubmed/31961880
http://dx.doi.org/10.1371/journal.pcbi.1007464
_version_ 1783493157801951232
author Padmanaban, Veena
Tsehay, Yohannes
Cheung, Kevin J.
Ewald, Andrew J.
Bader, Joel S.
author_facet Padmanaban, Veena
Tsehay, Yohannes
Cheung, Kevin J.
Ewald, Andrew J.
Bader, Joel S.
author_sort Padmanaban, Veena
collection PubMed
description For women with access to healthcare and early detection, breast cancer deaths are caused primarily by metastasis rather than growth of the primary tumor. Metastasis has been difficult to study because it happens deep in the body, occurs over years, and involves a small fraction of cells from the primary tumor. Furthermore, within-tumor heterogeneity relevant to metastasis can also lead to therapy failures and is obscured by studies of bulk tissue. Here we exploit heterogeneity to identify molecular mechanisms of metastasis. We use “organoids”, groups of hundreds of tumor cells taken from a patient and grown in the lab, to probe tumor heterogeneity, with potentially thousands of organoids generated from a single tumor. We show that organoids have the character of biological replicates: within-tumor and between-tumor variation are of similar magnitude. We develop new methods based on population genetics and variance components models to build between-tumor and within-tumor statistical tests, using organoids analogously to large sibships and vastly amplifying the test power. We show great efficiency for tests based on the organoids with the most extreme phenotypes and potential cost savings from pooled tests of the extreme tails, with organoids generated from hundreds of tumors having power predicted to be similar to bulk tests of hundreds of thousands of tumors. We apply these methods to an association test for molecular correlates of invasion, using a novel quantitative invasion phenotype calculated as the spectral power of the organoid boundary. These new approaches combine to show a strong association between invasion and protein expression of Keratin 14, a known biomarker for poor prognosis, with p = 2 × 10(−45) for within-tumor tests of individual organoids and p < 10(−6) for pooled tests of extreme tails. Future studies using these methods could lead to discoveries of new classes of cancer targets and development of corresponding therapeutics. All data and methods are available under an open source license at https://github.com/baderzone/invasion_2019.
format Online
Article
Text
id pubmed-6994152
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69941522020-02-18 Between-tumor and within-tumor heterogeneity in invasive potential Padmanaban, Veena Tsehay, Yohannes Cheung, Kevin J. Ewald, Andrew J. Bader, Joel S. PLoS Comput Biol Research Article For women with access to healthcare and early detection, breast cancer deaths are caused primarily by metastasis rather than growth of the primary tumor. Metastasis has been difficult to study because it happens deep in the body, occurs over years, and involves a small fraction of cells from the primary tumor. Furthermore, within-tumor heterogeneity relevant to metastasis can also lead to therapy failures and is obscured by studies of bulk tissue. Here we exploit heterogeneity to identify molecular mechanisms of metastasis. We use “organoids”, groups of hundreds of tumor cells taken from a patient and grown in the lab, to probe tumor heterogeneity, with potentially thousands of organoids generated from a single tumor. We show that organoids have the character of biological replicates: within-tumor and between-tumor variation are of similar magnitude. We develop new methods based on population genetics and variance components models to build between-tumor and within-tumor statistical tests, using organoids analogously to large sibships and vastly amplifying the test power. We show great efficiency for tests based on the organoids with the most extreme phenotypes and potential cost savings from pooled tests of the extreme tails, with organoids generated from hundreds of tumors having power predicted to be similar to bulk tests of hundreds of thousands of tumors. We apply these methods to an association test for molecular correlates of invasion, using a novel quantitative invasion phenotype calculated as the spectral power of the organoid boundary. These new approaches combine to show a strong association between invasion and protein expression of Keratin 14, a known biomarker for poor prognosis, with p = 2 × 10(−45) for within-tumor tests of individual organoids and p < 10(−6) for pooled tests of extreme tails. Future studies using these methods could lead to discoveries of new classes of cancer targets and development of corresponding therapeutics. All data and methods are available under an open source license at https://github.com/baderzone/invasion_2019. Public Library of Science 2020-01-21 /pmc/articles/PMC6994152/ /pubmed/31961880 http://dx.doi.org/10.1371/journal.pcbi.1007464 Text en © 2020 Padmanaban et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Padmanaban, Veena
Tsehay, Yohannes
Cheung, Kevin J.
Ewald, Andrew J.
Bader, Joel S.
Between-tumor and within-tumor heterogeneity in invasive potential
title Between-tumor and within-tumor heterogeneity in invasive potential
title_full Between-tumor and within-tumor heterogeneity in invasive potential
title_fullStr Between-tumor and within-tumor heterogeneity in invasive potential
title_full_unstemmed Between-tumor and within-tumor heterogeneity in invasive potential
title_short Between-tumor and within-tumor heterogeneity in invasive potential
title_sort between-tumor and within-tumor heterogeneity in invasive potential
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994152/
https://www.ncbi.nlm.nih.gov/pubmed/31961880
http://dx.doi.org/10.1371/journal.pcbi.1007464
work_keys_str_mv AT padmanabanveena betweentumorandwithintumorheterogeneityininvasivepotential
AT tsehayyohannes betweentumorandwithintumorheterogeneityininvasivepotential
AT cheungkevinj betweentumorandwithintumorheterogeneityininvasivepotential
AT ewaldandrewj betweentumorandwithintumorheterogeneityininvasivepotential
AT baderjoels betweentumorandwithintumorheterogeneityininvasivepotential